Latest Strategic Equity Investments News

LTR Pharma highlights SPONTAN's 5x faster absorption and validated safety, backed by over 1,000 Australian prescriptions and strategic partnerships as it targets FDA approval and US market entry.

Cambium Bio has clinched FDA agreement on a streamlined single pivotal Phase 3 trial for Elate Ocular®, cutting development complexity, while bolstering its cash position through a A$2.4 million strategic placement by major shareholder ZYBT.

Pantera Minerals spotlights the launch of EnergyX’s Lonestar lithium demonstration plant in Texas, marking a key step towards a 50,000 tonne per annum lithium production target in the US.

Austral Gold Limited has reported a return to profitability in FY25, driven by the reopening of its Casposo Mine and a significant increase in gold equivalent production. The company also strengthened its balance sheet through a successful private placement and equity investments.

Dateline Resources has acquired the Music Valley Heavy Rare Earths Project in California, backed by historical high-grade data, and invested US$1 million in Fermi Critical Minerals to boost exploration across the US. This move complements its existing gold and rare earth projects, positioning the company at the forefront of critical mineral supply chain security.

Perseus Mining reported a 5% revenue increase to US$608.5 million for the half-year ended December 2025, despite an 8% drop in net profit and a 26% decline in gold production. The company declared a steady interim dividend and outlined ongoing operational challenges and corporate restructuring.

Mitchell Services Limited reported a solid half-year performance with revenue up 3% to $102.4 million and EBITDA soaring 69% to $21.4 million, returning to profit after a prior loss. The company declared a fully franked 4 cent dividend, reflecting strong cash flow and disciplined capital management.

Star Minerals has entered a strategic partnership with Catalyst Metals, securing a gold milling agreement for its Tumblegum South project and selling its West Bryah Basin copper-gold assets for $2.75 million. Catalyst also commits to a $1 million equity placement in Star Minerals, underpinning the company’s development plans.

Viridis Mining and Minerals has achieved a critical environmental milestone for its Colossus Rare Earth Project in Brazil and secured significant financing commitments, positioning the project for construction in the second half of 2026.

Cambium Bio has strengthened its financial footing with a $0.6 million R&D tax refund and a $2.4 million strategic placement, setting the stage for pivotal Phase 3 clinical trials of its lead ophthalmology candidate.

CurveBeam AI has received official Chinese regulatory approval for a strategic $10 million investment from WEGO Orthopaedics, marking a major step in its expansion into Greater China. The initial $4 million tranche at a premium share price is expected imminently, underpinning a decade-long commercialisation deal.

Viridis Mining and Minerals has secured a pivotal US$50 million Letter of Support from Export Finance Australia, finalising the export credit agency-led debt package for its Colossus Rare Earths Project. This milestone positions the project to advance towards full funding and a Final Investment Decision in the second half of 2026.